• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Kidney Transplant Recipients With COVID-19 and Monoclonal Antibody Therapy: Additional Considerations.

作者信息

Mungmunpuntipantip Rujittika, Wiwanitkit Viroj

机构信息

Private Academic Consultant, Bangkok Thailand.

Dr DY Patil University, Pune, India.

出版信息

Kidney Med. 2022 Aug;4(8):100502. doi: 10.1016/j.xkme.2022.100502. Epub 2022 Jun 23.

DOI:10.1016/j.xkme.2022.100502
PMID:35765466
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9222405/
Abstract
摘要

相似文献

1
Kidney Transplant Recipients With COVID-19 and Monoclonal Antibody Therapy: Additional Considerations.接受新冠病毒治疗的肾移植受者与单克隆抗体疗法：更多考量
Kidney Med. 2022 Aug;4(8):100502. doi: 10.1016/j.xkme.2022.100502. Epub 2022 Jun 23.
2
Monoclonal Antibody Therapy in Kidney Transplant Recipients With Delta and Omicron Variants of SARS-CoV-2: A Single-Center Case Series.针对感染严重急性呼吸综合征冠状病毒2（SARS-CoV-2）Delta和Omicron变异株的肾移植受者的单克隆抗体治疗：一项单中心病例系列研究
Kidney Med. 2022 Jun;4(6):100470. doi: 10.1016/j.xkme.2022.100470. Epub 2022 Apr 27.
3
In Reply to 'Kidney Transplant Recipients With COVID-19 and Monoclonal Antibody Therapy: Additional Considerations'.回复《肾移植受者感染新型冠状病毒肺炎与单克隆抗体治疗：更多考量》
Kidney Med. 2022 Aug;4(8):100503. doi: 10.1016/j.xkme.2022.100503. Epub 2022 Jun 23.
4
Breakthrough COVID-19 after SARS-CoV-2 vaccination in solid organ transplant recipients: An analysis of symptomatic cases and monoclonal antibody therapy.SARS-CoV-2 疫苗接种后突破 COVID-19 在实体器官移植受者中的发生：症状病例分析和单克隆抗体治疗。
Transpl Infect Dis. 2022 Apr;24(2):e13779. doi: 10.1111/tid.13779. Epub 2022 Jan 31.
5
COVID-19 in kidney transplant recipients: A multicenter experience in Istanbul.肾移植受者中的新型冠状病毒肺炎：伊斯坦布尔的多中心经验
Transpl Infect Dis. 2020 Oct;22(5):e13371. doi: 10.1111/tid.13371. Epub 2020 Jul 13.
6
Safety and Efficacy of the COVID-19 Vaccine in Kidney Transplant Recipients.新冠疫苗在肾移植受者中的安全性和有效性
Cureus. 2022 May 5;14(5):e24753. doi: 10.7759/cureus.24753. eCollection 2022 May.
7
COVID-19 Infections in Pediatric Renal Transplant Recipients.儿童肾移植受者中的 COVID-19 感染。
Exp Clin Transplant. 2022 Mar;20(Suppl 1):156-160. doi: 10.6002/ect.MESOT2021.P82.
8
Outpatient management of kidney transplant recipients with suspected COVID-19-Single-center experience during the New York City surge.门诊管理疑似 COVID-19 的肾移植受者-纽约市疫情期间的单中心经验。
Transpl Infect Dis. 2020 Dec;22(6):e13383. doi: 10.1111/tid.13383. Epub 2020 Jul 6.
9
Antibody response to SARS-CoV-2 mRNA vaccine among kidney transplant recipients: a prospective cohort study.肾移植受者对 SARS-CoV-2 mRNA 疫苗的抗体反应：一项前瞻性队列研究。
Clin Microbiol Infect. 2021 Aug;27(8):1173.e1-1173.e4. doi: 10.1016/j.cmi.2021.04.028. Epub 2021 May 3.
10
The Impact of SARS-CoV-2 Infection, and Application of Immunosuppressive Agents in Kidney Transplant Recipients Suffering from COVID-19.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染的影响以及免疫抑制剂在感染2019冠状病毒病（COVID-19）的肾移植受者中的应用
Pharmaceuticals (Basel). 2021 Oct 17;14(10):1054. doi: 10.3390/ph14101054.

引用本文的文献

1
In Reply to 'Kidney Transplant Recipients With COVID-19 and Monoclonal Antibody Therapy: Additional Considerations'.回复《肾移植受者感染新型冠状病毒肺炎与单克隆抗体治疗：更多考量》
Kidney Med. 2022 Aug;4(8):100503. doi: 10.1016/j.xkme.2022.100503. Epub 2022 Jun 23.

本文引用的文献

1
Monoclonal Antibody Therapy in Kidney Transplant Recipients With Delta and Omicron Variants of SARS-CoV-2: A Single-Center Case Series.针对感染严重急性呼吸综合征冠状病毒2（SARS-CoV-2）Delta和Omicron变异株的肾移植受者的单克隆抗体治疗：一项单中心病例系列研究
Kidney Med. 2022 Jun;4(6):100470. doi: 10.1016/j.xkme.2022.100470. Epub 2022 Apr 27.
2
Letter to the Editor: Coronavirus Disease 2019 (COVID-19), Infectivity, and the Incubation Period.致编辑的信：2019冠状病毒病（COVID-19）、传染性与潜伏期
J Prev Med Public Health. 2020 Mar;53(2):70. doi: 10.3961/jpmph.20.065. Epub 2020 Mar 31.